Coronavirus Update:What patients and families need to know
The Children's National Research Institute
- M.B.Ch.B., Medicine and Surgery, University of Otago, Dunedin, New Zealand, (1986-1991)
- FRCPA, Hematology, Royal College of Pathologists of Australasia, Auckland, New Zealand, (1998-2002)
- FRCPA, Pediatrics, Royal Australasian College of Physicians, Auckland, New Zealand, (1995-2002)
- M.D., Immunology, University of Otago, Dunedin, New Zealand, (2000-2004)
Associate Center Director (ACD) Translational Research and Innovation, The George Washington Cancer Center
Professor of Pediatrics and of Microbiology, Immunology and Tropical Medicine, The George Washington University School of Medicine and Health Sciences
Catherine Bollard, M.B.Ch.B., M.D., is the Director of the Center for Cancer and Immunology Research at the Children’s National Research Institute, Director of the Program for Cell Enhancement and Technologies for Immunotherapy and a member of the Division of the Blood and Marrow Transplantation. In addition, she is Professor of Pediatrics and Microbiology, Immunology and Tropical Medicine at the George Washington University and is the ACD for Translational Research and Innovation within the George Washington Cancer Center. In these roles, Dr. Bollard leads clinical and research efforts to fight cancer and other inflammatory diseases by strengthening the immune system using adoptive cell therapy. As the immediate past president of the International Society of Cellular Therapy, she is a distinguished hematologist, immunologist and immunotherapist, working to develop cell and gene therapies for patients with cancer and underlying immune deficiencies.
Additionally, Dr. Bollard is interested in stem cell and cord blood transplantation and improving outcomes by decreasing infectious complications and preventing relapse. She also has a specific interest in targeting viral infections in the immune suppression population, including individuals living with human immunodeficiency virus. Dr. Bollard is a member of the American Society for Clinical Investigation and is on the Board of Directors of the Foundation for the Accreditation of Cellular Therapy and Chairs the Non-Hodgkin Lymphoma committee of the Children’s Oncology Group. She is an associate editor for the journals Blood and Cytotherapy. Dr. Bollard is a member of the National Cancer Institute Clinical Oncology Study Section and the Cellular, Tissues and Gene Therapies Advisory Committee for the Food and Drug Administration.
As a national and international leader in the immunology and immunotherapy space, Dr. Bollard’s work expands our understanding of cancer, immune deficiencies and viral infections in pediatric and adult patients. She joined Children’s National from the Baylor College of Medicine where she was a tenured professor in the Department of Pediatrics. Prior to that, she served as a Postdoctoral Fellow at Texas Children’s Hospital. She received a medical degree from Otago University Medical School in New Zealand.